{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:44:53Z","timestamp":1793731493518,"version":"4.6.1"},"reference-count":160,"publisher":"Bentham Science Publishers Ltd.","issue":"8","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CTMC"],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:sec><jats:title\/><jats:p>Undoubtedly, antibiotics have saved billions of lives, but lack of novel antibiotics, development of resistance mechanisms in almost all clinical isolates of bacteria, and recurrent infections caused by persistent bacteria hamper the successful treatment of the infections. Due to the widespread emergence of resistance, even the new families of anti-microbial agents have a short life expectancy. Drugs acting on a single target often lead to drug resistance and are associated with various side effects. For overcoming this problem, either multidrug therapy, or a single drug acting on multiple targets may be used. The latter is called \u2018hybrid molecules,\u2019 which are formed by clubbing two biologically active pharmacophores together, with or without an appropriate linker. In this rapidly evolving era, the development of natural product-based hybrid molecules may be a super-alternative to multidrug therapy, for combating drug resistance caused by various bacterial and fungal strains. Coumarins (benzopyran-2-one) are one of the earliest reported plant secondary metabolites having a clinically proven diverse range of pharmacological properties. On the other hand, 1,2,3-triazole is a common pharmacophore in many drugs responsible for polar interactions, improving the solubility and binding affinity to biomolecular targets. In this review, we discuss recent advances in Coumarin-1,2,3-triazole hybrids as potential anti-bacterial agents, aiming to provide a useful platform for the exploration of new leads with a broader spectrum, more effectiveness and less toxicity with multiple modes of action for the development of cost-effective and safer drugs in the future.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1568026621666210303145759","type":"journal-article","created":{"date-parts":[[2021,3,3]],"date-time":"2021-03-03T13:58:48Z","timestamp":1614779928000},"page":"737-752","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Coumarin-1,2,3-triazole Hybrid Molecules: An Emerging Scaffold for Combating Drug Resistance"],"prefix":"10.2174","volume":"21","author":[{"given":"Harish C.","family":"Upadhyay","sequence":"first","affiliation":[{"name":"Laboratory of Chemistry, Department of Applied Sciences, Rajkiya Engineering College (Affiliated to Dr. A.P.J. Abdul Kalam Technical University, Lucknow), Churk, Sonbhadra-231206,India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"63","DOI":"10.2174\/1875692116666180419153313","volume":"16","author":"Parasuraman S.","year":"2018","unstructured":"Parasuraman S.; Herbal drug discovery: Challenges and perspectives. Curr Pharmacogenomics Person Med 2018,16,63-68","journal-title":"Curr Pharmacogenomics Person Med"},{"key":"ref=2","author":"Samuelsson G.","year":"2004","unstructured":"Samuelsson G.; Drugs of Natural Origin: A Textbook of Pharmacognosy 2004","journal-title":"Drugs of Natural Origin: A Textbook of Pharmacognosy"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1021\/np9604893","volume":"60","author":"Cragg G.M.","year":"1997","unstructured":"Cragg G.M.; Newman D.J.; Snader K.M.; Natural products in drug discovery and development. J Nat Prod 1997,60(1),52-60","journal-title":"J Nat Prod"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3390\/molecules21050559","volume":"21","author":"Yuan H.","year":"2016","unstructured":"Yuan H.; Ma Q.; Ye L.; Piao G.; The traditional medicine and modern medicine from natural products. Molecules 2016,21(5),559","journal-title":"Molecules"},{"key":"ref=5","first-page":"74","volume":"39","author":"Sheng-Ji P.","year":"2001","unstructured":"Sheng-Ji P.; Ethnobotanical approaches of traditional medicine studies: some experiences from Asia. Pharm Biol 2001,39(Suppl. 1),74-79","journal-title":"Pharm Biol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1007\/s11606-008-0632-y","volume":"23","author":"Bent S.","year":"2008","unstructured":"Bent S.; Herbal medicine in the United States: review of efficacy, safety, and regulation: grand rounds at University of California, San Francisco Medical Center. J Gen Intern Med 2008,23(6),854-859","journal-title":"J Gen Intern Med"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.3389\/fphar.2019.01480","volume":"10","author":"Fitzgerald M.","year":"2020","unstructured":"Fitzgerald M.; Heinrich M.; Booker A.; Medicinal plant analysis: A historical and regional discussion of emergent complex techniques. Front Pharmacol 2020,10,1480","journal-title":"Front Pharmacol"},{"key":"ref=8","first-page":"1","volume":"1","author":"Verma N.","year":"2013","unstructured":"Verma N.; Herbal medicines: Regulation and practice in Europe, United States and India. Int J Herb Med 2013,1(4),1-5","journal-title":"Int J Herb Med"},{"key":"ref=9","year":"2020","unstructured":"WHO. Traditional medicine. Available from: (Accessed on June 10, 2020) 2020"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/B978-0-12-802104-0.00002-0","author":"Che C.T.","year":"2017","unstructured":"Che C.T.; George V.; Ijinu T.P.; Pushpangadan P.; Andrae-Marobela K.; Traditional medicine. Pharmacognosy: Fundamentals, Applications and Strategies 2017,15-30","journal-title":"Pharmacognosy: Fundamentals, Applications and Strategies"},{"key":"ref=11","doi-asserted-by":"publisher","DOI":"10.1201\/9780203719473","author":"Kapoor L.D.","year":"2017","unstructured":"Kapoor L.D.; Handbook of Ayurvedic Medicinal Plants 2017","journal-title":"Handbook of Ayurvedic Medicinal Plants"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1089\/acm.2012.0275","volume":"19","author":"Sahoo N.","year":"2013","unstructured":"Sahoo N.; Manchikanti P.; Herbal drug regulation and commercialization: an Indian industry perspective. J Altern Complement Med 2013,19(12),957-963","journal-title":"J Altern Complement Med"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.jtcme.2016.05.006","volume":"7","author":"Sen S.","year":"2016","unstructured":"Sen S.; Chakraborty R.; Revival, modernization and integration of Indian traditional herbal medicine in clinical practice: Importance, challenges and future. J Tradit Complement Med 2016,7(2),234-244","journal-title":"J Tradit Complement Med"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.amjmed.2003.10.036","volume":"116","author":"Bent S.","year":"2004","unstructured":"Bent S.; Ko R.; Commonly used herbal medicines in the United States: a review. Am J Med 2004,116(7),478-485","journal-title":"Am J Med"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.2174\/138161210793176464","volume":"16","author":"Hasani-Ranjbar S.","year":"2010","unstructured":"Hasani-Ranjbar S.; Nayebi N.; Moradi L.; Mehri A.; Larijani B.; Abdollahi M.; The efficacy and safety of herbal medicines used in the treatment of hyperlipidemia; a systematic review. Curr Pharm Des 2010,16(26),2935-2947","journal-title":"Curr Pharm Des"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"319","DOI":"10.4314\/ajtcam.v4i3.31226","volume":"4","author":"Ravishankar B.","year":"2007","unstructured":"Ravishankar B.; Shukla V.J.; Indian systems of medicine: a brief profile. Afr J Tradit Complement Altern Med 2007,4(3),319-337","journal-title":"Afr J Tradit Complement Altern Med"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1080\/14786419.2017.1356838","volume":"32","author":"Bernardini S.","year":"2018","unstructured":"Bernardini S.; Tiezzi A.; Laghezza Masci V.; Ovidi E.; Natural products for human health: an historical overview of the drug discovery approaches. Nat Prod Res 2018,32(16),1926-1950","journal-title":"Nat Prod Res"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/BF03020955","volume":"47","author":"Hamilton G.R.","year":"2000","unstructured":"Hamilton G.R.; Baskett T.F.; In the arms of Morpheus the development of morphine for postoperative pain relief. Can J Anaesth 2000,47(4),367-374","journal-title":"Can J Anaesth"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"861","DOI":"10.4103\/0019-5049.193696","volume":"60","author":"Krishnamurti C.","year":"2016","unstructured":"Krishnamurti C.; Rao S.C.; The isolation of morphine by Serturner. Indian J Anaesth 2016,60(11),861-862","journal-title":"Indian J Anaesth"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"366","DOI":"10.11622\/smedj.2015105","volume":"56","author":"Tan S.Y.","year":"2015","unstructured":"Tan S.Y.; Tatsumura Y.; Alexander Fleming (1881-1955): Discoverer of penicillin. Singapore Med J 2015,56(7),366-367","journal-title":"Singapore Med J"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s00253-011-3587-6","volume":"92","author":"Kardos N.","year":"2011","unstructured":"Kardos N.; Demain A.L.; Penicillin: the medicine with the greatest impact on therapeutic outcomes. Appl Microbiol Biotechnol 2011,92(4),677-687","journal-title":"Appl Microbiol Biotechnol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.3390\/ijms19061578","volume":"19","author":"Thomford N.E.","year":"2018","unstructured":"Thomford N.E.; Senthebane D.A.; Rowe A.; Munro D.; Seele P.; Maroyi A.; Dzobo K.; Natural products for drug discovery in the 21st century: Innovations for novel drug discovery. Int J Mol Sci 2018,19(6),1578","journal-title":"Int J Mol Sci"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.bcp.2005.10.012","volume":"71","author":"Butler M.S.","year":"2006","unstructured":"Butler M.S.; Buss A.D.; Natural products--the future scaffolds for novel antibiotics? Biochem Pharmacol 2006,71(7),919-929","journal-title":"Biochem Pharmacol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/j.1465-0691.2004.1007.x","volume":"10","author":"Powers J.H.","year":"2004","unstructured":"Powers J.H.; Antimicrobial drug development--the past, the present, and the future. Clin Microbiol Infect 2004,10(4)(Suppl. 4),23-31","journal-title":"Clin Microbiol Infect"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/nrd940","volume":"1","author":"Coates A.","year":"2002","unstructured":"Coates A.; Hu Y.; Bax R.; Page C.; The future challenges facing the development of new antimicrobial drugs. Nat Rev Drug Discov 2002,1(11),895-910","journal-title":"Nat Rev Drug Discov"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.lfs.2005.09.012","volume":"78","author":"Balunas M.J.","year":"2005","unstructured":"Balunas M.J.; Kinghorn A.D.; Drug discovery from medicinal plants. Life Sci 2005,78(5),431-441","journal-title":"Life Sci"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"784","DOI":"10.2174\/1568026619666190412101047","volume":"19","author":"Upadhyay H.C.","year":"2019","unstructured":"Upadhyay H.C.; Medicinal chemistry of alternative therapeutics: Novelty and hopes with genus Ammannia. Curr Top Med Chem 2019,19(10),784-794","journal-title":"Curr Top Med Chem"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"469","DOI":"10.2174\/157018011795514249","volume":"8","author":"Khan F.","year":"2011","unstructured":"Khan F.; Yadav D.K.; Maurya A.; Sonia; Srivastava, S.K. Modern methods and web resources in drug design","journal-title":"Lett Drug Des Discov"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ejps.2012.05.009","volume":"47","author":"Maurya A.","year":"2012","unstructured":"Maurya A.; Khan F.; Bawankule D.U.; Yadav D.K.; Srivastava S.K.; QSAR, docking and in vivo studies for immunomodulatory activity of isolated triterpenoids from Eucalyptus tereticornis and Gentiana kurroo. Eur J Pharm Sci 2012,47(1),152-161","journal-title":"Eur J Pharm Sci"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1093\/chromsci\/bms099","volume":"51","author":"Upadhyay H.C.","year":"2013","unstructured":"Upadhyay H.C.; Verma R.K.; Srivastava S.K.; Quantitative determination of bioactive 4-hydroxy-&#x3B1;-tetralone, tetralone-4-O-&#x3B2;-D-glucopyranoside and ellagic acid in Ammannia baccifera (Linn.) by reversed-phase high-performance liquid chromatography. J Chromatogr Sci 2013,51(1),21-25","journal-title":"J Chromatogr Sci"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.2174\/0929867325666180501102450","volume":"27","author":"Varela M.T.","year":"2020","unstructured":"Varela M.T.; Fernandes J.P.S.; Natural Products: Key prototypes to drug discovery against neglected diseases caused by Trypanosomatids. Curr Med Chem 2020,27(13),2133-2146","journal-title":"Curr Med Chem"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"847","DOI":"10.2174\/1568026619666190412120008","volume":"19","author":"Dwivedi G.R.","year":"2019","unstructured":"Dwivedi G.R.; Maurya A.; Yadav D.K.; Khan F.; Gupta M.K.; Gupta P.; Darokar M.P.; Srivastava S.K.; Comparative drug resistance reversal potential of natural glycosides synergy potential of niaziridin","journal-title":"Curr Top Med Chem"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1177\/1934578X1200700724","volume":"7","author":"Upadhyay H.C.","year":"2012","unstructured":"Upadhyay H.C.; Jaiswal N.; Tamrakar A.K.; Srivastava A.K.; Gupta N.; Srivastava S.K.; Antihyperglycemic agents from Ammannia multiflora. Nat Prod Commun 2012,7(7),899-900","journal-title":"Nat Prod Commun"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1111\/cbdd.12263","volume":"83","author":"Dwivedi G.R.","year":"2014","unstructured":"Dwivedi G.R.; Upadhyay H.C.; Yadav D.K.; Singh V.; Srivastava S.K.; Khan F.; Darmwal N.S.; Darokar M.P.; 4-Hydroxy-&#x3B1;-tetralone and its derivative as drug resistance reversal agents in multi drug resistant Escherichia coli. Chem Biol Drug Des 2014,83(4),482-492","journal-title":"Chem Biol Drug Des"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1002\/cmdc.201402027","volume":"9","author":"Upadhyay H.C.","year":"2014","unstructured":"Upadhyay H.C.; Dwivedi G.R.; Roy S.; Sharma A.; Darokar M.P.; Srivastava S.K.; Phytol derivatives as drug resistance reversal agents. ChemMedChem 2014,9(8),1860-1868","journal-title":"ChemMedChem"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1007\/s00044-017-2132-2","volume":"27","author":"Saxena A.","year":"2018","unstructured":"Saxena A.; Upadhyay H.C.; Cheema H.S.; Srivastava S.K.; Darokar M.P.; Bawankule D.U.; Antimalarial activity of phytol derivatives: in vitro and in vivo study. Med Chem Res 2018,27(5),1345-1354","journal-title":"Med Chem Res"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"169","DOI":"10.2174\/157019312800604706","volume":"9","author":"Das B.","year":"2012","unstructured":"Das B.; Satyalakshmi G.; Natural products based anticancer agents. Mini Rev Org Chem 2012,9(2),169-177","journal-title":"Mini Rev Org Chem"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1007\/s00894-011-1327-6","volume":"18","author":"Kalani K.","year":"2012","unstructured":"Kalani K.; Yadav D.K.; Khan F.; Srivastava S.K.; Suri N.; Pharmacophore, QSAR, and ADME based semisynthesis and in vitro evaluation of ursolic acid analogs for anticancer activity. J Mol Model 2012,18(7),3389-3413","journal-title":"J Mol Model"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.2174\/09298673113206660330","volume":"21","author":"Yadav D.K.","year":"2014","unstructured":"Yadav D.K.; Kalani K.; Singh A.K.; Khan F.; Srivastava S.K.; Pant A.B.; Design, synthesis and in vitro evaluation of 18&#x3B2;-glycyrrhetinic acid derivatives for anticancer activity against human breast cancer cell line MCF-7. Curr Med Chem 2014,21(9),1160-1170","journal-title":"Curr Med Chem"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1021\/np030096l","volume":"66","author":"Newman D.J.","year":"2003","unstructured":"Newman D.J.; Cragg G.M.; Snader K.M.; Natural products as sources of new drugs over the period 1981-2002. J Nat Prod 2003,66(7),1022-1037","journal-title":"J Nat Prod"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1021\/np200906s","volume":"75","author":"Newman D.J.","year":"2012","unstructured":"Newman D.J.; Cragg G.M.; Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod 2012,75(3),311-335","journal-title":"J Nat Prod"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3390\/metabo2020303","volume":"2","author":"Dias D.A.","year":"2012","unstructured":"Dias D.A.; Urban S.; Roessner U.; A historical overview of natural products in drug discovery. Metabolites 2012,2(2),303-336","journal-title":"Metabolites"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.2174\/0929867043365116","volume":"11","author":"Vuorelaa P.","year":"2004","unstructured":"Vuorelaa P.; Leinonenb M.; Saikkuc P.; Tammelaa P.; Rauhad J.P.; Wennberge T.; Vuorela H.; Natural products in the process of finding new drug candidates. Curr Med Chem 2004,11(11),1375-1389","journal-title":"Curr Med Chem"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"5887","DOI":"10.2174\/0929867326666190618113613","volume":"27","author":"Panda S.S.","year":"2019","unstructured":"Panda S.S.; Jhanji N.; Natural products as potential anti-Alzheimer agents. Curr Med Chem 2019,27(35),5887-5917","journal-title":"Curr Med Chem"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"4918","DOI":"10.2174\/0929867324666170523120656","volume":"25","author":"Manayi A.","year":"2018","unstructured":"Manayi A.; Nabavi S.M.; Setzer W.N.; Jafari S.; Piperine as a potential anti-cancer agent: A review on preclinical studies. Curr Med Chem 2018,25(37),4918-4928","journal-title":"Curr Med Chem"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1517\/17460441.3.5.487","volume":"3","author":"Silver L.L.","year":"2008","unstructured":"Silver L.L.; Are natural products still the best source for antibacterial discovery? The bacterial entry factor. Expert Opin Drug Discov 2008,3(5),487-500","journal-title":"Expert Opin Drug Discov"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.cell.2007.03.004","volume":"128","author":"Alekshun M.N.","year":"2007","unstructured":"Alekshun M.N.; Levy S.B.; Molecular mechanisms of antibacterial multidrug resistance. Cell 2007,128(6),1037-1050","journal-title":"Cell"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/S1473-3099(13)70318-9","volume":"13","author":"Laxminarayan R.","year":"2013","unstructured":"Laxminarayan R.; Duse A.; Wattal C.; Zaidi A.K.M.; Wertheim H.F.L.; Sumpradit N.; Vlieghe E.; Hara G.L.; Gould I.M.; Goossens H.; Greko C.; So A.D.; Bigdeli M.; Tomson G.; Woodhouse W.; Ombaka E.; Peralta A.Q.; Qamar F.N.; Mir F.; Kariuki S.; Bhutta Z.A.; Coates A.; Bergstrom R.; Wright G.D.; Brown E.D.; Cars O.; Antibiotic resistance-the need for global solutions. Lancet Infect Dis 2013,13(12),1057-1098","journal-title":"Lancet Infect Dis"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"e1403","DOI":"10.7759\/cureus.1403","volume":"9","author":"Zaman S.B.","year":"2017","unstructured":"Zaman S.B.; Hussain M.A.; Nye R.; Mehta V.; Mamun K.T.; Hossain N.; A Review on antibiotic resistance: Alarm bells are ringing. Cureus 2017,9(6),e1403","journal-title":"Cureus"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"E3463","DOI":"10.1073\/pnas.1717295115","volume":"115","author":"Klein E.Y.","year":"2018","unstructured":"Klein E.Y.; Van Boeckel T.P.; Martinez E.M.; Pant S.; Gandra S.; Levin S.A.; Goossens H.; Laxminarayan R.; Global increase and geographic convergence in antibiotic consumption between 2000 and 2015. Proc Natl Acad Sci USA 2018,115(15),E3463-E3470","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=51","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.VMBF-0016-2015","volume":"4","author":"Munita J.M.","year":"2016","unstructured":"Munita J.M.; Arias C.A.; Mechanisms of antibiotic resistance. Microbiol Spectr 2016,4(2)","journal-title":"Microbiol Spectr"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1111\/1751-7915.13587","volume":"13","author":"Udaondo Z.","year":"2020","unstructured":"Udaondo Z.; Huertas M.J.; Fighting the enemy: one health approach against microbial resistance. Microb Biotechnol 2020,13(4),888-891","journal-title":"Microb Biotechnol"},{"key":"ref=53","first-page":"35","volume":"13","author":"Dwivedi G.R.","year":"2017","unstructured":"Dwivedi G.R.; Singh A.; Upadhyay H.C.; Pati S.; Singh D.P.; Prasad K.N.; Darokar M.P.; Srivastava S.K.; Determination of drug resistance mechanism (s) of clinical isolates of P. aeruginosa and phytoextract as drug resistance reversal agent. EC Microbiol 2017,13(1),35-41","journal-title":"EC Microbiol"},{"key":"ref=54","year":"2020","unstructured":"WHO. Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. Available from: (Accessed on June 10, 2020)2020"},{"key":"ref=55","doi-asserted-by":"publisher","DOI":"10.1126\/science.aal0829","author":"Vogel G.","year":"2017","unstructured":"Vogel G.; Meet WHO\u2019s dirty dozen: The 12 bacteria for which new drugs are most urgently needed. Science 2017","journal-title":"Science"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1080\/03009734.2016.1195900","volume":"121","author":"Jasovsk&#xFD; D.","year":"2016","unstructured":"Jasovsk&#xFD; D.; Littmann J.; Zorzet A.; Cars O.; Antimicrobial resistance-a threat to the world\u2019s sustainable development. Ups J Med Sci 2016,121(3),159-164","journal-title":"Ups J Med Sci"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"e1002184","DOI":"10.1371\/journal.pmed.1002184","volume":"13","author":"de Kraker M.E.","year":"2016","unstructured":"de Kraker M.E.; Stewardson A.J.; Harbarth S.; Will 10 million people die a year due to antimicrobial resistance by 2050? PLoS Med 2016,13(11),e1002184","journal-title":"PLoS Med"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1038\/ja.2017.124","volume":"70","author":"Simpkin V.L.","year":"2017","unstructured":"Simpkin V.L.; Renwick M.J.; Kelly R.; Mossialos E.; Incentivising innovation in antibiotic drug discovery and development: progress, challenges and next steps. J Antibiot (Tokyo) 2017,70(12),1087-1096","journal-title":"J Antibiot (Tokyo)"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"25","DOI":"10.4137\/PMC.S14459","volume":"6","author":"Fair R.J.","year":"2014","unstructured":"Fair R.J.; Tor Y.; Antibiotics and bacterial resistance in the 21st century. Perspect Medicin Chem 2014,6,25-64","journal-title":"Perspect Medicin Chem"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.mib.2017.10.028","volume":"39","author":"Theuretzbacher U.","year":"2017","unstructured":"Theuretzbacher U.; Global antimicrobial resistance in Gram-negative pathogens and clinical need. Curr Opin Microbiol 2017,39,106-112","journal-title":"Curr Opin Microbiol"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"S231","DOI":"10.2337\/dc11-s235","volume":"34","author":"Miccoli R.","year":"2011","unstructured":"Miccoli R.; Penno G.; Del Prato S.; Multidrug treatment of type 2 diabetes: a challenge for compliance. Diabetes Care 2011,34(2 Suppl. 2),S231-S235","journal-title":"Diabetes Care"},{"key":"ref=62","first-page":"665","volume":"3","author":"Derosa G.","year":"2007","unstructured":"Derosa G.; Sibilla S.; Optimizing combination treatment in the management of type 2 diabetes. Vasc Health Risk Manag 2007,3(5),665-671","journal-title":"Vasc Health Risk Manag"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.ejmech.2014.03.018","volume":"77","author":"Nepali K.","year":"2014","unstructured":"Nepali K.; Sharma S.; Sharma M.; Bedi P.M.S.; Dhar K.L.; Rational approaches, design strategies, structure activity relationship and mechanistic insights for anticancer hybrids. Eur J Med Chem 2014,77,422-487","journal-title":"Eur J Med Chem"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"6523","DOI":"10.1021\/jm058225d","volume":"48","author":"Morphy R.","year":"2005","unstructured":"Morphy R.; Rankovic Z.; Designed multiple ligands: An emerging drug discovery paradigm. J Med Chem 2005,48(21),6523-6543.","journal-title":"J Med Chem"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"383","DOI":"10.2174\/9781681080765115040008","volume":"Vol. 14","author":"Mehndiratta S.","year":"2015","unstructured":"Mehndiratta S.; Sharma S.; Kumar K.; Nepali K.; Molecular hybrids with anticancer activity. Topics in Anti-Cancer Research 2015,Vol. 14,383-454","journal-title":"Topics in Anti-Cancer Research"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"4106","DOI":"10.2174\/1381612821666150506154434","volume":"21","author":"Younis W.","year":"2015","unstructured":"Younis W.; Thangamani S.; Seleem M.N.; Repurposing non-antimicrobial drugs and clinical molecules to treat bacterial infections. Curr Pharm Des 2015,21(28),4106-4111","journal-title":"Curr Pharm Des"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"310","DOI":"10.4103\/0972-5229.132495","volume":"18","author":"Ahmed A.","year":"2014","unstructured":"Ahmed A.; Azim A.; Gurjar M.; Baronia A.K.; Current concepts in combination antibiotic therapy for critically ill patients. Indian J Crit Care Med 2014,18(5),310-314","journal-title":"Indian J Crit Care Med"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1128\/CMR.05041-11","volume":"25","author":"Tamma P.D.","year":"2012","unstructured":"Tamma P.D.; Cosgrove S.E.; Maragakis L.L.; Combination therapy for treatment of infections with gram-negative bacteria. Clin Microbiol Rev 2012,25(3),450-470","journal-title":"Clin Microbiol Rev"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.ejmech.2016.08.039","volume":"124","author":"Shaveta","year":"2016","unstructured":"Shaveta ; Mishra S.; Singh P.; Hybrid molecules: The privileged scaffolds for various pharmaceuticals. Eur J Med Chem 2016,124,500-536","journal-title":"Eur J Med Chem"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1021\/ar7000843","volume":"41","author":"Meunier B.","year":"2008","unstructured":"Meunier B.; Hybrid molecules with a dual mode of action: dream or reality? Acc Chem Res 2008,41(1),69-77","journal-title":"Acc Chem Res"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1517\/17460441.2010.508069","volume":"5","author":"Pokrovskaya V.","year":"2010","unstructured":"Pokrovskaya V.; Baasov T.; Dual-acting hybrid antibiotics: a promising strategy to combat bacterial resistance. Expert Opin Drug Discov 2010,5(9),883-902","journal-title":"Expert Opin Drug Discov"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1080\/17460441.2016.1187597","volume":"11","author":"Parkes A.L.","year":"2016","unstructured":"Parkes A.L.; Yule I.A.; Hybrid antibiotics - clinical progress and novel designs. Expert Opin Drug Discov 2016,11(7),665-680","journal-title":"Expert Opin Drug Discov"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1517\/17460441.2016.1135125","volume":"11","author":"B&#xE9;rub&#xE9; G.","year":"2016","unstructured":"B&#xE9;rub&#xE9; G.; An overview of molecular hybrids in drug discovery. Expert Opin Drug Discov 2016,11(3),281-305","journal-title":"Expert Opin Drug Discov"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ejmech.2018.03.057","volume":"151","author":"Choudhary S.","year":"2018","unstructured":"Choudhary S.; Singh P.K.; Verma H.; Singh H.; Silakari O.; Success stories of natural product-based hybrid molecules for multi-factorial diseases. Eur J Med Chem 2018,151,62-97","journal-title":"Eur J Med Chem"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.2174\/092986711795328355","volume":"18","author":"Decker M.","year":"2011","unstructured":"Decker M.; Hybrid molecules incorporating natural products: applications in cancer therapy, neurodegenerative disorders and beyond. Curr Med Chem 2011,18(10),1464-1475","journal-title":"Curr Med Chem"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"3996","DOI":"10.1002\/anie.200200553","volume":"42","author":"Tietze L.F.","year":"2003","unstructured":"Tietze L.F.; Bell H.P.; Chandrasekhar S.; Natural product hybrids as new leads for drug discovery. Angew Chem Int Ed Engl 2003,42(34),3996-4028","journal-title":"Angew Chem Int Ed Engl"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/cbdd.12629","volume":"87","author":"Jameel E.","year":"2016","unstructured":"Jameel E.; Umar T.; Kumar J.; Hoda N.; Coumarin: A privileged scaffold for the design and development of antineurodegenerative agents. Chem Biol Drug Des 2016,87(1),21-38","journal-title":"Chem Biol Drug Des"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1080\/07352689.2011.616039","volume":"31","author":"Gnonlonfin G.B.","year":"2012","unstructured":"Gnonlonfin G.B.; Sanni A.; Brimer L.; Review scopoletin\u2013a coumarin phytoalexin with medicinal properties. Crit Rev Plant Sci 2012,31,47-53","journal-title":"Crit Rev Plant Sci"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3923\/rjphyto.2011.170.176","volume":"5","author":"Upadhyay H.C.","year":"2011","unstructured":"Upadhyay H.C.; Saini D.C.; Srivastava S.K.; Phytochemical analysis of Ammannia multiflora. Res J Phytochem 2011,5,170-176","journal-title":"Res J Phytochem"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1055\/s-0031-1280256","volume":"78","author":"Upadhyay H.C.","year":"2012","unstructured":"Upadhyay H.C.; Dwivedi G.R.; Darokar M.P.; Chaturvedi V.; Srivastava S.K.; Bioenhancing and antimycobacterial agents from Ammannia multiflora. Planta Med 2012,78(1),79-81","journal-title":"Planta Med"},{"key":"ref=81","first-page":"318","volume":"13","author":"Bubols G.B.","year":"2013","unstructured":"Bubols G.B.; Vianna Dda.R.; Medina-Remon A.; von Poser G.; Lamuela-Raventos R.M.; Eifler-Lima V.L.; Garcia S.C.; The antioxidant activity of coumarins and flavonoids. Mini Rev Med Chem 2013,13(3),318-334","journal-title":"Mini Rev Med Chem"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1177\/1934578X1300801123","volume":"8","author":"Upadhyay H.C.","year":"2013","unstructured":"Upadhyay H.C.; Sisodia B.S.; Cheema H.S.; Agrawal J.; Pal A.; Darokar M.P.; Srivastava S.K.; Novel antiplasmodial agents from Christia vespertilionis. Nat Prod Commun 2013,8(11),1591-1594","journal-title":"Nat Prod Commun"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.bmc.2011.12.042","volume":"20","author":"Anand P.","year":"2012","unstructured":"Anand P.; Singh B.; Singh N.; A review on coumarins as acetylcholinesterase inhibitors for Alzheimer\u2019s disease. Bioorg Med Chem 2012,20(3),1175-1180","journal-title":"Bioorg Med Chem"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.2174\/1568026615666150427125916","volume":"15","author":"Vazquez-Rodriguez S.","year":"2015","unstructured":"Vazquez-Rodriguez S.; Matos M.J.; Borges F.; Uriarte E.; Santana L.; Bioactive coumarins from marine sources: Origin, structural features and pharmacological properties. Curr Top Med Chem 2015,15(17),1755-1766","journal-title":"Curr Top Med Chem"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1177\/1934578X0900401219","volume":"4","author":"Rosselli S.","year":"2009","unstructured":"Rosselli S.; Maggio A.M.; Faraone N.; Spadaro V.; Morris-Natschke S.L.; Bastow K.F.; Lee K-H.; Bruno M.; The cytotoxic properties of natural coumarins isolated from roots of Ferulago campestris (Apiaceae) and of synthetic ester derivatives of aegelinol. Nat Prod Commun 2009,4(12),1701-1706","journal-title":"Nat Prod Commun"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/j.phymed.2014.06.017","volume":"21","author":"Khaw K.Y.","year":"2014","unstructured":"Khaw K.Y.; Choi S.B.; Tan S.C.; Wahab H.A.; Chan K.L.; Murugaiyah V.; Prenylated xanthones from mangosteen as promising cholinesterase inhibitors and their molecular docking studies. Phytomedicine 2014,21(11),1303-1309","journal-title":"Phytomedicine"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1007\/s00044-013-0682-5","volume":"23","author":"Upadhyay H.C.","year":"2014","unstructured":"Upadhyay H.C.; Sisodia B.S.; Agrawal J.; Pal A.; Darokar M.P.; Srivastava S.K.; Antimalarial potential of extracts and isolated compounds from four species of genus Ammannia. Med Chem Res 2014,23,870-876","journal-title":"Med Chem Res"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.3109\/13880209.2013.790453","volume":"51","author":"Upadhyay H.C.","year":"2013","unstructured":"Upadhyay H.C.; Sisodia B.S.; Verma R.K.; Darokar M.P.; Srivastava S.K.; Antiplasmodial potential of extracts from two species of genus Blumea. Pharm Biol 2013,51(10),1326-1330","journal-title":"Pharm Biol"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.apjtm.2016.01.014","volume":"9","author":"Ali M.Y.","year":"2016","unstructured":"Ali M.Y.; Jannat S.; Jung H.A.; Choi R.J.; Roy A.; Choi J.S.; Anti-Alzheimer\u2019s disease potential of coumarins from Angelica decursiva and Artemisia capillaris and structure-activity analysis. Asian Pac J Trop Med 2016,9(2),103-111","journal-title":"Asian Pac J Trop Med"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"124","DOI":"10.2174\/1568026618666180329115523","volume":"18","author":"Pereira T.M.","year":"2018","unstructured":"Pereira T.M.; Franco D.P.; Vitorio F.; Kummerle A.E.; Coumarin compounds in medicinal chemistry: some important examples from the last years. Curr Top Med Chem 2018,18(2),124-148","journal-title":"Curr Top Med Chem"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s00044-012-9998-9","volume":"22","author":"Upadhyay H.C.","year":"2013","unstructured":"Upadhyay H.C.; Thakur J.P.; Saikia D.; Srivastava S.K.; Anti-tubercular agents from Ammannia baccifera (Linn.). Med Chem Res 2013,22,16-21","journal-title":"Med Chem Res"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"13","DOI":"10.5530\/srp.2017.1.4","volume":"8","author":"Rudrapal M.","year":"2017","unstructured":"Rudrapal M.; Chetia D.; Plant flavonoids as potential source of future antimalarial leads. Sys Rev Pharm 2017,8(1),13-18","journal-title":"Sys Rev Pharm"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"4131","DOI":"10.1021\/jm00078a001","volume":"36","author":"Patil A.D.","year":"1993","unstructured":"Patil A.D.; Freyer A.J.; Eggleston D.S.; Haltiwanger R.C.; Bean M.F.; Taylor P.B.; Caranfa M.J.; Breen A.L.; Bartus H.R.; Johnson R.K.; The inophyllums, novel inhibitors of HIV-1 reverse transcriptase isolated from the Malaysian tree, Calophyllum inophyllum Linn. J Med Chem 1993,36(26),4131-4138","journal-title":"J Med Chem"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"3475","DOI":"10.1016\/S0960-894X(98)00628-3","volume":"8","author":"Spino C.","year":"1998","unstructured":"Spino C.; Dodier M.; Sotheeswaran S.; Anti-HIV coumarins from Calophyllum seed oil. Bioorg Med Chem Lett 1998,8(24),3475-3478","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/emm.2005.54","volume":"37","author":"Whang W.K.","year":"2005","unstructured":"Whang W.K.; Park H.S.; Ham I.; Oh M.; Namkoong H.; Kim H.K.; Hwang D.W.; Hur S.Y.; Kim T.E.; Park Y.G.; Kim J.R.; Kim J.W.; Natural compounds,fraxin and chemicals structurally related to fraxin protect cells from oxidative stress. Exp Mol Med 2005,37(5),436-446","journal-title":"Exp Mol Med"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1248\/bpb.33.1610","volume":"33","author":"Shin E.","year":"2010","unstructured":"Shin E.; Choi K.M.; Yoo H.S.; Lee C.K.; Hwang B.Y.; Lee M.K.; Inhibitory effects of coumarins from the stem barks of Fraxinus rhynchophylla on adipocyte differentiation in 3T3-L1 cells. Biol Pharm Bull 2010,33(9),1610-1614","journal-title":"Biol Pharm Bull"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/S0944-7113(00)80075-6","volume":"6","author":"Fort D.M.","year":"2000","unstructured":"Fort D.M.; Rao K.; Jolad S.D.; Luo J.; Carlson T.J.; King S.R.; Antihyperglycemic activity of Teramnus labialis (Fabaceae). Phytomedicine 2000,6(6),465-467","journal-title":"Phytomedicine"},{"key":"ref=98","first-page":"554","volume":"56","author":"Piller N.B.","year":"1975","unstructured":"Piller N.B.; A comparison of the effectiveness of some anti-inflammatory drugs on thermal oedema. Br J Exp Pathol 1975,56(6),554-560","journal-title":"Br J Exp Pathol"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1111\/j.1747-0285.2011.01173.x","volume":"78","author":"Meena A.","year":"2011","unstructured":"Meena A.; Yadav D.K.; Srivastava A.; Khan F.; Chanda D.; Chattopadhyay S.K.; In silico exploration of anti-inflammatory activity of natural coumarinolignoids. Chem Biol Drug Des 2011,78(4),567-579","journal-title":"Chem Biol Drug Des"},{"key":"ref=100","first-page":"173","volume":"4","author":"Yadav D.K.","year":"2010","unstructured":"Yadav D.K.; Meena A.; Srivastava A.; Chanda D.; Khan F.; Chattopadhyay S.K.; Development of QSAR model for immunomodulatory activity of natural coumarinolignoids. Drug Des Devel Ther 2010,4,173-186","journal-title":"Drug Des Devel Ther"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"113","DOI":"10.2174\/1389557516666160801094919","volume":"18","author":"Srikrishna D.","year":"2018","unstructured":"Srikrishna D.; Godugu C.; Dubey P.K.; A review on pharmacological properties of coumarins. Mini Rev Med Chem 2018,18(2),113-141","journal-title":"Mini Rev Med Chem"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.ejmech.2015.07.010","volume":"101","author":"Thakur A.","year":"2015","unstructured":"Thakur A.; Singla R.; Jaitak V.; Coumarins as anticancer agents: a review on synthetic strategies, mechanism of action and SAR studies. Eur J Med Chem 2015,101,476-495","journal-title":"Eur J Med Chem"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2174\/1568026618666180221114515","volume":"18","author":"Ren Q-C.","year":"2018","unstructured":"Ren Q-C.; Gao C.; Xu Z.; Feng L-S.; Liu M-L.; Wu X.; Zhao F.; Bis-coumarin derivatives and their biological activities. Curr Top Med Chem 2018,18(2),101-113","journal-title":"Curr Top Med Chem"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.ejmech.2017.06.051","volume":"138","author":"Zhang S.","year":"2017","unstructured":"Zhang S.; Xu Z.; Gao C.; Ren Q-C.; Chang L.; Lv Z-S.; Feng L-S.; Triazole derivatives and their anti-tubercular activity. Eur J Med Chem 2017,138,501-513","journal-title":"Eur J Med Chem"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"8644","DOI":"10.1016\/j.bmc.2006.08.019","volume":"14","author":"Costa M.S.","year":"2006","unstructured":"Costa M.S.; Boechat N.; Rangel E.A.; da Silva Fde.C.; de Souza A.M.; Rodrigues C.R.; Castro H.C.; Junior I.N.; Louren&#xE7;o M.C.; Wardell S.M.; Ferreira V.F.; Synthesis, tuberculosis inhibitory activity, and SAR study of N-substituted-phenyl-1,2,3-triazole derivatives. Bioorg Med Chem 2006,14(24),8644-8653","journal-title":"Bioorg Med Chem"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.bioorg.2017.01.010","volume":"71","author":"Dheer D.","year":"2017","unstructured":"Dheer D.; Singh V.; Shankar R.; Medicinal attributes of 1,2,3-triazoles: Current developments. Bioorg Chem 2017,71,30-54","journal-title":"Bioorg Chem"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.ejmech.2019.02.055","volume":"168","author":"Zhang B.","year":"2019","unstructured":"Zhang B.; Comprehensive review on the anti-bacterial activity of 1,2,3-triazole hybrids. Eur J Med Chem 2019,168,357-372","journal-title":"Eur J Med Chem"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1007\/s11030-011-9319-0","volume":"15","author":"Labadie G.R.","year":"2011","unstructured":"Labadie G.R.; de la Iglesia A.; Morbidoni H.R.; Targeting tuberculosis through a small focused library of 1,2,3-triazoles. Mol Divers 2011,15(4),1017-1024","journal-title":"Mol Divers"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.2174\/1389557519666190312162601","volume":"19","author":"Jain A.","year":"2019","unstructured":"Jain A.; Piplani P.; Exploring the chemistry and therapeutic potential of triazoles: A comprehensive literature review. Mini Rev Med Chem 2019,19(16),1298-1368","journal-title":"Mini Rev Med Chem"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2174\/092986712803414213","volume":"19","author":"Zhou C.H.","year":"2012","unstructured":"Zhou C.H.; Wang Y.; Recent researches in triazole compounds as medicinal drugs. Curr Med Chem 2012,19(2),239-280","journal-title":"Curr Med Chem"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"137","DOI":"10.2165\/00003495-198020020-00007","volume":"20","author":"Weinstein A.J.","year":"1980","unstructured":"Weinstein A.J.; The cephalosporins: activity and clinical use. Drugs 1980,20(2),137-154","journal-title":"Drugs"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1111\/j.1528-1167.2008.01665.x","volume":"49","author":"Perucca E.","year":"2008","unstructured":"Perucca E.; Cloyd J.; Critchley D.; Fuseau E.; Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy. Epilepsia 2008,49(7),1123-1141","journal-title":"Epilepsia"},{"key":"ref=113","first-page":"799","volume":"24","author":"Soltis M.J.","year":"1996","unstructured":"Soltis M.J.; Yeh H.J.; Cole K.A.; Whittaker N.; Wersto R.P.; Kohn E.C.; Identification and characterization of human metabolites of CAI [5-amino-1-1(4\u2032-chlorobenzoyl-3,5-dichlorobenzyl)-1,2,3-triazole- 4-carboxamide). Drug Metab Dispos 1996,24(7),799-806","journal-title":"Drug Metab Dispos"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"111587","DOI":"10.1016\/j.ejmech.2019.111587","volume":"181","author":"Zhang L.","year":"2019","unstructured":"Zhang L.; Xu Z.; Coumarin-containing hybrids and their anticancer activities. Eur J Med Chem 2019,181,111587","journal-title":"Eur J Med Chem"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"3806","DOI":"10.1016\/j.bmc.2014.05.032","volume":"22","author":"Sandhu S.","year":"2014","unstructured":"Sandhu S.; Bansal Y.; Silakari O.; Bansal G.; Coumarin hybrids as novel therapeutic agents. Bioorg Med Chem 2014,22(15),3806-3814","journal-title":"Bioorg Med Chem"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"e1900380","DOI":"10.1002\/ardp.201900380","volume":"353","author":"Feng D.","year":"2020","unstructured":"Feng D.; Zhang A.; Yang Y.; Yang P.; Coumarin-containing hybrids and their antibacterial activities. Arch Pharm (Weinheim) 2020,353(6),e1900380","journal-title":"Arch Pharm (Weinheim)"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.ejmech.2015.08.033","volume":"102","author":"Emami S.","year":"2015","unstructured":"Emami S.; Dadashpour S.; Current developments of coumarin-based anti-cancer agents in medicinal chemistry. Eur J Med Chem 2015,102,611-630","journal-title":"Eur J Med Chem"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.2174\/1389557519666190308122509","volume":"19","author":"Bhatia R.","year":"2019","unstructured":"Bhatia R.; Rawal R.K.; Coumarin hybrids: Promising scaffolds in the treatment of breast cancer. Mini Rev Med Chem 2019,19(17),1443-1458","journal-title":"Mini Rev Med Chem"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0065-7743(08)00017-1","volume":"43","author":"Barbachyn M.R.","year":"2008","unstructured":"Barbachyn M.R.; Recent advances in the discovery of hybrid antibacterial agents. Annu Rep Med Chem 2008,43,281-290","journal-title":"Annu Rep Med Chem"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.coph.2008.06.008","volume":"8","author":"Br&#xF6;tz-Oesterhelt H.","year":"2008","unstructured":"Br&#xF6;tz-Oesterhelt H.; Brunner N.A.; How many modes of action should an antibiotic have? Curr Opin Pharmacol 2008,8(5),564-573","journal-title":"Curr Opin Pharmacol"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1070\/RCR4448","volume":"84","author":"Tevyashova A.N.","year":"2015","unstructured":"Tevyashova A.N.; Olsufyeva E.N.; Preobrazhenskaya M.N.; Design of dual action antibiotics as an approach to search for new promising drugs. Russ Chem Rev 2015,84,61","journal-title":"Russ Chem Rev"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.3390\/ijms19041104","volume":"19","author":"Pawe\u0142czyk A.","year":"2018","unstructured":"Pawe\u0142czyk A.; Sowa-Kasprzak K.; Olender D.; Zaprutko L.; Molecular consortia-various structural and synthetic concepts for more effective therapeutics synthesis. Int J Mol Sci 2018,19(4),1104","journal-title":"Int J Mol Sci"},{"key":"ref=123","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/ddr.20345","volume":"71","author":"Muregi F.W.","year":"2010","unstructured":"Muregi F.W.; Ishih A.; Next-generation antimalarial drugs: hybrid molecules as a new strategy in drug design. Drug Dev Res 2010,71(1),20-32","journal-title":"Drug Dev Res"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.bmc.2016.12.019","volume":"25","author":"Elshemy H.A.H.","year":"2017","unstructured":"Elshemy H.A.H.; Zaki M.A.; Design and synthesis of new coumarin hybrids and insight into their mode of antiproliferative action. Bioorg Med Chem 2017,25(3),1066-1075","journal-title":"Bioorg Med Chem"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"3477","DOI":"10.1016\/j.bmc.2019.06.033","volume":"27","author":"Singh H.","year":"2019","unstructured":"Singh H.; Singh J.V.; Bhagat K.; Gulati H.K.; Sanduja M.; Kumar N.; Kinarivala N.; Sharma S.; Rational approaches, design strategies, structure activity relationship and mechanistic insights for therapeutic coumarin hybrids. Bioorg Med Chem 2019,27(16),3477-3510","journal-title":"Bioorg Med Chem"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"3974","DOI":"10.1016\/j.bmcl.2017.07.069","volume":"27","author":"Singh H.","year":"2017","unstructured":"Singh H.; Singh J.V.; Gupta M.K.; Saxena A.K.; Sharma S.; Nepali K.; Bedi P.M.S.; Triazole tethered isatin-coumarin based molecular hybrids as novel antitubulin agents: Design, synthesis, biological investigation and docking studies. Bioorg Med Chem Lett 2017,27(17),3974-3979","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"46394","DOI":"10.1039\/C6RA07071J","volume":"6","author":"Gaudino E.C.","year":"2016","unstructured":"Gaudino E.C.; Tagliapietra S.; Martina K.; Palmisano G.; Cravotto G.; Recent advances and perspectives in the synthesis of bioactive coumarins. RSC Advances 2016,6,46394-46405","journal-title":"RSC Advances"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ejmech.2016.03.087","volume":"119","author":"Dandriyal J.","year":"2016","unstructured":"Dandriyal J.; Singla R.; Kumar M.; Jaitak V.; Recent developments of C-4 substituted coumarin derivatives as anticancer agents. Eur J Med Chem 2016,119,141-168","journal-title":"Eur J Med Chem"},{"key":"ref=129","first-page":"3219","volume":"17","author":"Hu X.L.","year":"2017","unstructured":"Hu X.L.; Xu Z.; Liu M.L.; Feng L.S.; Zhang G.D.; Recent developments of coumarin hybrids as anti-fungal agents. Curr Top Med Chem 2017,17(29),3219-3231","journal-title":"Curr Top Med Chem"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1111\/cbdd.13316","volume":"92","author":"Hiremathad A.","year":"2018","unstructured":"Hiremathad A.; Chand K.; Keri R.S.; Development of coumarin-benzofuran hybrids as versatile multitargeted compounds for the treatment of Alzheimer\u2019s Disease. Chem Biol Drug Des 2018,92(2),1497-1503","journal-title":"Chem Biol Drug Des"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1080\/00397911.2020.1743318","volume":"51","author":"Sanand S.M.H.","year":"2020","unstructured":"Sanand S.M.H.; Mekky A.E.M.; Synthesis, in-vitro antibacterial and anticancer screening of novel nicotinonitrile-coumarin hybrids utilizing piperazine citrate. Synth Commun 2020,51(4),1468-1485","journal-title":"Synth Commun"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"3420","DOI":"10.1002\/slct.201904783","volume":"5","author":"Khanna L.","year":"2020","unstructured":"Khanna L.; Singhal S.; Jain S.C.; Khanna P.; Spiro-Indole-Coumarin Hybrids: Synthesis, ADME, DFT, NBO studies and in silico screening through molecular docking on DNA G-quadruplex. ChemistrySelect 2020,5(11),3420-3433","journal-title":"ChemistrySelect"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.bioorg.2016.08.005","volume":"68","author":"Ibrar A.","year":"2016","unstructured":"Ibrar A.; Tehseen Y.; Khan I.; Hameed A.; Saeed A.; Furtmann N.; Bajorath J.; Iqbal J.; Coumarin-thiazole and -oxadiazole derivatives: Synthesis, bioactivity and docking studies for aldose\/aldehyde reductase inhibitors. Bioorg Chem 2016,68,177-186","journal-title":"Bioorg Chem"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1016\/j.drudis.2017.05.014","volume":"22","author":"Bonandi E.","year":"2017","unstructured":"Bonandi E.; Christodoulou M.S.; Fumagalli G.; Perdicchia D.; Rastelli G.; Passarella D.; The 1,2,3-triazole ring as a bioisostere in medicinal chemistry. Drug Discov Today 2017,22(10),1572-1581","journal-title":"Drug Discov Today"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/14756360903524304","volume":"26","author":"Kharb R.","year":"2011","unstructured":"Kharb R.; Sharma P.C.; Yar M.S.; Pharmacological significance of triazole scaffold. J Enzyme Inhib Med Chem 2011,26(1),1-21","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1517\/14656566.2015.1057500","volume":"16","author":"Chitasombat M.N.","year":"2015","unstructured":"Chitasombat M.N.; Kontoyiannis D.P.; The \u2018cephalosporin era\u2019 of triazole therapy: isavuconazole, a welcomed newcomer for the treatment of invasive fungal infections. Expert Opin Pharmacother 2015,16(10),1543-1558","journal-title":"Expert Opin Pharmacother"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1002\/asia.201100432","volume":"6","author":"Agalave S.G.","year":"2011","unstructured":"Agalave S.G.; Maujan S.R.; Pore V.S.; Click chemistry: 1,2,3-triazoles as pharmacophores. Chem Asian J 2011,6(10),2696-2718","journal-title":"Chem Asian J"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/chin.200528145","volume":"44B","author":"Kusanur R.A.","year":"2005","unstructured":"Kusanur R.A.; Kulkarni M.V.; New 1,3-dipolar cycloadducts of 3-azidoacetylcoumarins with DMAD and their antimicrobial activity. Indian J Chem 2005,44B,591-594","journal-title":"Indian J Chem"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1016\/j.bmcl.2014.02.027","volume":"24","author":"Kushwaha K.","year":"2014","unstructured":"Kushwaha K.; Kaushik N.; Lata ; Jain S.C.; Design and synthesis of novel 2H-chromen-2-one derivatives bearing 1,2,3-triazole moiety as lead antimicrobials. Bioorg Med Chem Lett 2014,24(7),1795-1801","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1515\/hc-2014-0102","volume":"20","author":"Dongamanti A.","year":"2014","unstructured":"Dongamanti A.; Bommidi V.L.; Arram G.; Sidda R.; Microwave-assisted synthesis of (E)-7-[(1-benzyl-1H-1,2,3-triazol-4-yl)methoxy]-8-(3-arylacryloyl)-4-methyl-2Hchromen-2-ones and their antimicrobial activity. Heterocycl Commun 2014,20,293-298","journal-title":"Heterocycl Commun"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1007\/s00044-016-1519-9","volume":"25","author":"Shaikh M.H.","year":"2016","unstructured":"Shaikh M.H.; Subhedar D.D.; Shingate B.B.; Khan F.A.K.; Sangshetti J.N.; Khedkar V.M.; Nawale L.; Sarkar D.; Navale G.R.; Shinde S.S.; Synthesis, biological evaluation and molecular docking of novel coumarin incorporated triazoles as antitubercular, antioxidant and antimicrobial agents. Med Chem Res 2016,25,790-804","journal-title":"Med Chem Res"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.ejmech.2016.08.062","volume":"124","author":"Kraljevi\u0107 T.G.","year":"2016","unstructured":"Kraljevi\u0107 T.G.; Harej A.; Sedi\u0107 M.; Paveli\u0107 S.K.; Stepani\u0107 V.; Drenjan&#x10D;evi\u0107 D.; Talapko J.; Rai\u0107-Mali\u0107 S.; Synthesis, in&#xA0;vitro anticancer and antibacterial activities and in silico studies of new 4-substituted 1,2,3-triazole-coumarin hybrids. Eur J Med Chem 2016,124,794-808","journal-title":"Eur J Med Chem"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1007\/s11426-015-0351-0","volume":"59","author":"Peng X.","year":"2016","unstructured":"Peng X.; Kumar K.V.; Damu G.L.V.; Zhou C-H.; Coumarin-derived azolyl ethanols: Synthesis, antimicrobial evaluation and preliminary action mechanism. Sci China Chem 2016,59,878-894","journal-title":"Sci China Chem"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.3109\/14756366.2016.1158171","volume":"31","author":"Zayane M.","year":"2016","unstructured":"Zayane M.; Rahmouni A.; Daami-Remadi M.; Ben Mansour M.; Romdhane A.; Ben Jannet H.; Design and synthesis of antimicrobial, anticoagulant, and anticholinesterase hybrid molecules from 4-methylumbelliferone. J Enzyme Inhib Med Chem 2016,31(6),1566-1575","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1007\/s00044-016-1549-3","volume":"25","author":"Kumar S.","year":"2016","unstructured":"Kumar S.; Prasad S.; Kumar B.; Gautam H.K.; Sharma S.K.; Synthesis of novel triazolyl pyranochromen-2(1H)-ones and their antibacterial activity evaluation. Med Chem Res 2016,25,1057-1073","journal-title":"Med Chem Res"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s12039-016-1214-x","volume":"129","author":"Yadav P.","year":"2017","unstructured":"Yadav P.; Kumar B.; Gautam H.K.; Sharma S.K.; Synthesis and antibacterial activity screening of quaternary ammonium derivatives of triazolyl pyranochromenones. J Chem Sci 2017,129,211-222","journal-title":"J Chem Sci"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3390\/molecules23010199","volume":"23","author":"L&#xF3;pez-Rojas P.","year":"2018","unstructured":"L&#xF3;pez-Rojas P.; Janeczko M.; Kubi\u0144ski K.; Amesty &#xC1;.; Mas\u0142yk M.; Est&#xE9;vez-Braun A.; Synthesis and antimicrobial activity of 4-substituted 1,2,3-triazole-coumarin derivatives. Molecules 2018,23(1),199","journal-title":"Molecules"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1002\/jhet.3175","volume":"55","author":"Kolichala N.","year":"2018","unstructured":"Kolichala N.; Thummala B.; Karkala V.K.P.; Regioselective synthesis and antibacterial activity studies of 1,2,3-triazol-4-yl]-4-methyl-2H-chromen-2-ones. J Heterocycl Chem 2018,55(6),1398-1402","journal-title":"J Heterocycl Chem"},{"key":"ref=149","first-page":"3213","volume":"17","author":"Jin X.","year":"2017","unstructured":"Jin X.; Xu Y.; Yang X.; Chen X.; Wu M.; Guan J.; Feng L.; Design, Synthesis and in vitro anti-microbial evaluation of ethylene\/propylene-1H-1,2,3-triazole-4-methylene-tethered isatin-coumarin hybrids. Curr Top Med Chem 2017,17(29),3213-3218","journal-title":"Curr Top Med Chem"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.cdc.2018.09.005","volume":"17-18","author":"Madar J.M.","year":"2018","unstructured":"Madar J.M.; Shastri L.A.; Shastri S.L.; Guda R.; Holiyachi M.; Naik N.S.; Dodamani D.; Jalapre S.; Sungar V.A.; Design and synthesis of structurally identical coumarinotriazoles as cytotoxic and antimicrobial agents Chem. Data Collect 2018,17-18,219-235","journal-title":"Data Collect"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.3390\/molecules24112126","volume":"24","author":"Lipeeva A.V.","year":"2019","unstructured":"Lipeeva A.V.; Zakharov D.O.; Burova L.G.; Frolova T.S.; Baev D.S.; Shirokikh I.V.; Evstropov A.N.; Sinitsyna O.I.; Tolsikova T.G.; Shults E.E.; Design, synthesis and antibacterial activity of coumarin-1,2,3-triazole hybrids obtained from natural furocoumarin peucedanin. Molecules 2019,24(11),2126","journal-title":"Molecules"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"8720","DOI":"10.1021\/acsomega.8b02481","volume":"4","author":"Bhagat K.","year":"2019","unstructured":"Bhagat K.; Bhagat J.; Gupta M.K.; Singh J.V.; Gulati H.K.; Singh A.; Kaur K.; Kaur G.; Sharma S.; Rana A.; Singh H.; Sharma S.; Singh Bedi P.M.; Design, synthesis, antimicrobial evaluation, and molecular modeling studies of novel indolinedione\u2212coumarin molecular hybrids. ACS Omega 2019,4(5),8720-8730","journal-title":"ACS Omega"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s12039-020-1748-9","volume":"132","author":"Ashok D.","year":"2020","unstructured":"Ashok D.; Reddy M.R.; Dharavath R.; Ramakrishna K.; Nagaraju N.; Sarasija M.; Microwave-assisted synthesis of some new 1,2,3-triazole derivatives and their antimicrobial activity. J Chem Sci 2020,132,47","journal-title":"J Chem Sci"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"11615","DOI":"10.1039\/D0RA01052A","volume":"10","author":"Dharavath R.","year":"2020","unstructured":"Dharavath R.; Nagaraju N.; Reddy M.R.; Ashok D.; Sarasija M.; Vijjulatha M.; Vani T.; Jyothi K.; Prashanthi G.; Microwave-assisted synthesis, biological evaluation and molecular docking studies of new coumarin-based-1,2,3-triazoles. RSC Advances 2020,10,11615-11623","journal-title":"RSC Advances"},{"key":"ref=155","first-page":"53","volume":"64","author":"Joy M.N.","year":"2020","unstructured":"Joy M.N.; Bodke Y.D.; Telkar S.; Bakulev V.A.; Synthesis of coumarins linked with 1,2,3-triazoles under microwave irradiation and evaluation of their antimicrobial and antioxidant activity. J Mex Chem Soc 2020,64(1),53-73","journal-title":"J Mex Chem Soc"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/j.1747-0285.2012.01441.x","volume":"80","author":"Naik R.J.","year":"2012","unstructured":"Naik R.J.; Kulkarni M.V.; Sreedhara Ranganath Pai K.; Nayak P.G.; Click chemistry approach for bis-chromenyl triazole hybrids and their antitubercular activity. Chem Biol Drug Des 2012,80(4),516-523","journal-title":"Chem Biol Drug Des"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.ejmech.2015.10.019","volume":"105","author":"Anand A.","year":"2015","unstructured":"Anand A.; Naik R.J.; Revankar H.M.; Kulkarni M.V.; Dixit S.R.; Joshi S.D.; A click chemistry approach for the synthesis of mono and bis aryloxy linked coumarinyl triazoles as anti-tubercular agents. Eur J Med Chem 2015,105,194-207","journal-title":"Eur J Med Chem"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"e1900013","DOI":"10.1002\/ardp.201900013","volume":"352","author":"Somagond S.M.","year":"2019","unstructured":"Somagond S.M.; Kamble R.R.; Bayannavar P.K.; Shaikh S.K.J.; Joshi S.D.; Kumbar V.M.; Nesaragi A.R.; Kariduraganavar M.Y.; Click chemistry based regioselective one-pot synthesis of coumarin-3-yl-methyl-1,2,3-triazolyl-1,2,4-triazol-3(4H)-ones as newer potent antitubercular agents. Arch Pharm (Weinheim) 2019,352(10),e1900013","journal-title":"Arch Pharm (Weinheim)"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"115054","DOI":"10.1016\/j.bmc.2019.115054","volume":"27","author":"Khanapurmath N.","year":"2019","unstructured":"Khanapurmath N.; Kulkarni M.V.; Joshi S.D.; Anil Kumar G.N.; A click chemistry approach for the synthesis of cyclic ureido tethered coumarinyl and 1-aza coumarinyl 1,2,3-triazoles as inhibitors of Mycobacterium tuberculosis H37Rv and their in silico studies. Bioorg Med Chem 2019,27(20),115054","journal-title":"Bioorg Med Chem"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"4709","DOI":"10.1016\/j.bmcl.2016.08.045","volume":"26","author":"Anand A.","year":"2016","unstructured":"Anand A.; Kulkarni M.V.; Joshi S.D.; Dixit S.R.; One pot Click chemistry: A three component reaction for the synthesis of 2-mercaptobenzimidazole linked coumarinyl triazoles as anti-tubercular agents. Bioorg Med Chem Lett 2016,26(19),4709-4713","journal-title":"Bioorg Med Chem Lett"}],"container-title":["Current Topics in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1568026621666210303145759","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/192036\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1568026621666210303145759","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T09:56:17Z","timestamp":1697968577000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/192036\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":160,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1568026621666210303145759","relation":{},"ISSN":["1568-0266"],"issn-type":[{"value":"1568-0266","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-06-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-03","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}